Pacer Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Pacer Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,209	Closed	-$14K	–	1391
2017 Q3	$14K	Buy	+1,209	New	+$13.3K	﹤0.01%	1178

Pacer Advisors's SCLN Position: Q4 2017 in Review

Pacer Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 1,209 shares — an estimated $14K sold.

Pacer Advisors first reported a position in SCLN in Q3 2017 and held it in 1 quarter. The position peaked at $14K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Pacer Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Pacer Advisors sold 1,209 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $14K.
Pacer Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
Pacer Advisors's Sciclone Pharmaceuticals Inc position peaked at $14K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.